ArticleScientific reports2026
Enhancing Alzheimer's disease classification with a transformer-based model using self-supervised learning.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- FUSION-AD: interpretable AI framework for risk assessment and subgroup discovery in Alzheimer's disease.Frontiers in neuroinformatics · 2026Article
- TriFusion-ADFormer: a deep learning framework for early Alzheimer's disease detection using MRI and cognitive metrics.Frontiers in artificial intelligence · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Alzheimer's disease (AD) is a progressive neurodegenerative disease and the current diagnosis tools, which are used, including clinical examination and neuroimaging, are costly, time consuming and complicated to generalize across demographics. Traditional machine learning (ML) methods such as Support Vector Machines (SVM), LightGBM, and Random Forest (RF) are known to be having weakness in terms of feature selection, class imbalance, and generalization. This paper presents a new Enhanced TabTransformer with Self-Supervised Learning (ETT-SSL) framework of AD classification. The structure combines the transformer-based architecture, self-supervised learning (SSL) for feature representation, SHAP-based feature selection, and the use of SMOTE to balance classes. Experimental results also indicate that ETT-SSL reaches a high accuracy of 95.8%, which is a much better result than baseline models (SVM: 72.1, RF: 78.3, LightGBM: 80.5) and even the standard TabTransformer (85.2%). Additionally, ETT-SSL offers greater accuracy and improved recall, overcoming the issue of false negatives in AD diagnosis. SHAP analysis can be used to improve transparency in clinical decision-making by making use of the model interpretability. The proposed framework recommends a salivary, interpretability and clinically practical methodology that can be used to expand to multimodal data source (e.g. MRI scans, genomic markers and electronic health records) to improve accuracy and generalisability.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.